Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Companies

Results 1 - 1 out of 1 displayed.
 
Search filter:
  • Search for: Company
Sort direction:
Sort direction:
 |   |   | 
Headquarters
Foster City, California, USA
Main sector:
  • Pharma (fully integrated)
Subsector:
  • Anti-infectives
  • Antibodies
  • Antibody-drug-conjugate
  • Cell therapy
  • Small molecule therapeutics
Indications:
  • Cardiovascular / cardiology
  • Digestive system / gastroenterology
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Genitourinary system / Urology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
  • Respiratory / pulmonology
  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Employees:
  • Worldwide: 18,000
Products:
  • In development: 71
  • On the market: 15
Description:
Gilead Sciences Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, and commercialization of medicines for the treatment of cardiovascular, hematological, and respiratory diseases, inflammation, liver diseases, cancer, and human immunodeficiency virus (HIV) infection. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. The company's...

Already have a valid Biotechgate account? Login here »

Get access to Biotechgate

Download complete company profiles including product pipelines, financing rounds and management details.


to the top ↑